CELLMP Trademark

Trademark Overview

On Tuesday, October 23, 2018, a trademark application was filed for CELLMP with the United States Patent and Trademark Office. The USPTO has given the CELLMP trademark a serial number of 88166146. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, August 14, 2025. This trademark is owned by Cell Manufacturing and Production, LLC. The CELLMP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development consultation in the fields of bioengineering, biotechnology, cell therapy, and ophthalmology; consulting services in the fields of bioengineering, biotechnology, cell therapy, and ophthalmology
cellmp

General Information

Serial Number88166146
Word MarkCELLMP
Filing DateTuesday, October 23, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, August 14, 2025
Registration Number6030133
Registration DateTuesday, April 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Pseudo MarkCELL MANUFACTURING AND PRODUCTION
Goods and ServicesResearch and development consultation in the fields of bioengineering, biotechnology, cell therapy, and ophthalmology; consulting services in the fields of bioengineering, biotechnology, cell therapy, and ophthalmology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 29, 2019
Primary Code042
First Use Anywhere DateWednesday, August 22, 2018
First Use In Commerce DateThursday, August 23, 2018

Trademark Owner History

Party NameCell Manufacturing and Production, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameCell Manufacturing and Production, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameCell Manufacturing and Production, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Wednesday, February 6, 2019NON-FINAL ACTION WRITTEN
Friday, October 26, 2018NEW APPLICATION ENTERED
Monday, November 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 30, 2019ASSIGNED TO EXAMINER
Wednesday, February 6, 2019NON-FINAL ACTION E-MAILED
Wednesday, February 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, July 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 13, 2019ASSIGNED TO LIE
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Monday, August 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2020TEAS STATEMENT OF USE RECEIVED
Monday, January 27, 2020USE AMENDMENT FILED
Wednesday, February 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 12, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 4, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 5, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Monday, April 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 9, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, August 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

cellmp cell therapy ophthalmology bioengineering biotechnology fields services consulting consultation research